Albireo Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Albireo Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ALBO

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. 

CEO
Christelle Huguet, PhD
CEOChristelle Huguet, PhD
Employees
Employees
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2003
Founded2003
Employees
Employees

ALBO Key Statistics

Market cap
915.89M
Market cap915.89M
Price-Earnings ratio
-6.57
Price-Earnings ratio-6.57
Dividend yield
Dividend yield
Average volume
1.00M
Average volume1.00M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$45.23
52 Week high$45.23
52 Week low
$16.02
52 Week low$16.02

Stock Snapshot

The current Albireo Pharma(ALBO) stock price is $44.15, with a market capitalization of 915.89M. The stock trades at a price-to-earnings (P/E) ratio of -6.57.

During the trading day, Albireo Pharma(ALBO) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Albireo Pharma(ALBO) stock has reached 0, versus its average volume of 1M.

The stock's 52-week range extends from a low of $16.02 to a high of $45.23.

The stock's 52-week range extends from a low of $16.02 to a high of $45.23.

People also own

Based on the portfolios of people who own ALBO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.